Dynamic Technology Lab Private LTD Mannkind Corp Transaction History

Dynamic Technology Lab Private LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.62 - $4.45 $64,884 - $110,204	-24,765 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.05 - $5.37 $46,182 - $61,234	11,403 Added 85.34%	24,765 $108,000
Q3 2021 Nov 15, 2021	BUY	$3.89 - $5.48 $51,978 - $73,223	13,362 New	13,362 $58,000

243

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.